
Twelve years of multiples investors have paid for Artemis Medicare Services Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Artemis Medicare Services Ltd trades at a P/E of 118.38×.
Twelve years of audited numbers for Artemis Medicare Services Ltd, switchable between annual and quarterly views, consolidated or standalone.
Artemis Medicare Services Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current reported EPS of ₹2.29.
Disclosed business segments at Artemis Medicare Services with their share of revenue and profit, switchable between consolidated and standalone reporting.
Artemis Medicare Services discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Why someone would buy Artemis Medicare Services Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Artemis Medicare Services Ltd's investment case rests on 9 positive markers and 8 flagged concerns drawn from the latest reported filings.
Strong operating profit margin (11.51%) and ROE (12.90%) indicate efficient operations.
Robust quarterly sales growth (14.20%) and consistent revenue expansion.
Significant promoter holding (66.5%) signals strong insider confidence and stability.
Favorable P/E ratio (39.20) compared to peers suggests potential valuation upside.
Impressive 5-year EPS CAGR (28.78%) and EBITDA CAGR (23.72%) demonstrate strong growth.
Stock exhibits considerable volatility, with a wide 52-week price range.
Decline in promoter shareholding (69.59% to 66.53%) warrants careful monitoring.
High Price-to-Book ratio (4.53) suggests potential overvaluation by some metrics.
Moderate debt-to-equity ratio (0.35) and total debt (₹290 Cr) require observation.
Very low dividend yield (0.17%) may not attract income-focused investors.
Trim if P/E re-rates above 154. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 28.31. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Artemis Medicare Services Ltd is highlighted for quick read-across.
| Company Name |
|---|
Dr Agarwals Health Care Ltd |
Apollo Hospitals Enterprise Ltd |
Artemis Medicare Services LtdCurrent Stock |
Aster DM Healthcare Ltd |
Fortis Healthcare Ltd |
GPT Healthcare Ltd |
Healthcare Global Enterprises Ltd |
Indraprastha Medical Corporation Ltd |
Jupiter Life Line Hospitals Ltd |
Krishna Institute of Medical Sciences Ltd |
Lotus Eye Hospital & Institute Ltd |
Max Healthcare Institute Ltd |
Global Health Ltd |
Narayana Hrudayalaya Ltd |
Rainbow Childrens Medicare Ltd |
Shalby Ltd |
Yatharth Hospital & Trauma Care Services Ltd |
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Artemis Medicare Services Ltd — derived from the live tape, not yesterday's close.
Artemis Medicare Services Ltd last traded at ₹268.2 with an intraday range of ₹267.1–₹276.8 — live indicator, pivot and CPR signals below.
Standard pivot — most widely referenced.
| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 293.70 | +25.50 | +9.51% |
| R3 | 284.00 | +15.80 | +5.89% |
| R2 | 280.40 | +12.20 | +4.55% |
| R1 | 274.30 | +6.10 | +2.27% |
| PIVOT | 270.70 | 2.50 | 0.93% |
| CURRENT | 268.20 | — | — |
| S1 | 245.20 | -23.00 | -8.58% |
| S2 | 254.90 | -13.30 | -4.96% |
| S3 | 261.00 | -7.20 | -2.68% |
| S4 | 264.60 | -3.60 | -1.34% |
ARTEMISMED is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 270.5 ~ 276.8
Trading Inside opening range
Daily traded volume and delivery percentage for Artemis Medicare Services Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Artemis Medicare Services Ltd stood at 54.4% of traded volume, against a 20-day average of 51.6%.
Filings Artemis Medicare Services sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Every dividend, stock split and bonus issue Artemis Medicare Services has declared, sequenced by announce and record date.
Artemis Medicare Services corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
What Artemis Medicare Services Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Artemis Medicare Services Ltd is a listed Indian equity, listed as NSE: ARTEMISMED, BSE: 542919.

Artemis Medicare Services Limited is a healthcare provider operating primarily in India, with international expansion. Their core business revolves around the management and operation of multi-specialty hospitals, delivering a comprehensive range of medical services.
The company's flagship facility is Artemis Hospital, a multi-specialty hospital situated in Gurugram, India. This hospital offers a wide spectrum of medical and surgical interventions, catering to both inpatient and outpatient needs. This includes a broad scope of services extending beyond basic medical care.
Beyond direct medical treatment, Artemis provides extensive ancillary services designed to enhance the patient experience and overall healthcare journey. These services encompass billing and insurance assistance, childcare, emotional and support programs, international patient services, translation and record management, nutritional guidance, patient advocacy, pre-admission testing, smoking cessation programs, and executive health checks. They also offer workplace clinics for counseling and various healthcare education and awareness initiatives.
Furthermore, Artemis's service offerings extend to emergency services, first aid and BLS training, and organizational healthcare audits. This diversified approach positions them as a holistic healthcare provider, addressing not only immediate medical needs but also preventative care, patient support, and broader healthcare system optimization.
In summary, Artemis Medicare Services Limited is a vertically integrated healthcare company focused on delivering high-quality medical care and a comprehensive support system. Their business model combines direct patient care with ancillary services aimed at improving the overall patient experience and promoting wellness.
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
The current share price of Artemis Medicare Services Ltd (ARTEMISMED) is ₹268.2. Today, the stock has declined by ₹2.90 (1.07%), trading in a range of ₹267.1 to ₹276.8. The stock opened at ₹271.4 with a trading volume of 1,09,214 shares.
Artemis Medicare Services Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹0 crores, P/E ratio of 118.38, ROE of 11.63%, and ROCE of 14.60%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Artemis Medicare Services Ltd (ARTEMISMED) is ₹297.5, while the 52-week low is ₹203.35. Currently trading at ₹268.2, the stock is 68.9% away from its 52-week low and 9.8% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Artemis Medicare Services Ltd stock at ₹268.2 depends on multiple factors. The stock is currently trading with a P/E ratio of 118.38 and P/B ratio of N/A. Today's performance shows a loss of 1.07%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Artemis Medicare Services Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹268.2, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Artemis Medicare Services Ltd's key financial metrics include: P/E Ratio: 118.38, P/B Ratio: N/A, ROE: 11.63%, ROCE: 14.60%, Dividend Yield: 0.00%, EPS: ₹2.29, Book Value: ₹59.16, Debt-to-Equity: 27.81, and Current Ratio: N/A. The company's market cap stands at ₹0 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Artemis Medicare Services Ltd stock opened at ₹271.4 and is currently trading at ₹268.2, showing a decline of ₹2.90 (1.07%). The intraday high is ₹276.8 and low is ₹267.1. The trading volume stands at 1,09,214 shares, indicating moderate market participation today.
Artemis Medicare Services Ltd has a Price-to-Earnings (P/E) ratio of 118.38, which means investors are willing to pay ₹118.38 for every ₹1 of earnings. With an EPS of ₹2.29, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Artemis Medicare Services Ltd (ARTEMISMED) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Peers, sector trends, screeners and strategy playbooks contextual to this stock.